| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 96.77% | 98.42% | 99.53% | 97.25% | 98.68% | 97.30% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 3.23% | 1.58% | 0.47% | 2.75% | 1.32% | 2.70% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Healthcare | 3,53,687 | 328.63 | 9.39% | -0.15%↓ |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 15,95,093 | 289.76 | 8.28% | -0.66%↓ |
| Alkem Laboratories Ltd. | Healthcare | 3,14,859 | 162.58 | 4.64% | 1.58%↑ |
| Cipla Ltd. | Healthcare | 10,80,050 | 145.37 | 4.15% | 0.21%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1,58,200 | 129.18 | 3.69% | 2.30%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 2,66,486 | 127.91 | 3.65% | -0.43%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 13,59,696 | 126.42 | 3.61% | -0.45%↓ |
| Aster DM Quality Care Ltd. | Healthcare | 17,86,027 | 124.51 | 3.56% | -0.28%↓ |
| Lupin Ltd. | Healthcare | 6,11,505 | 124.15 | 3.55% | -0.49%↓ |
| Neuland Laboratories Ltd. | Healthcare | 53,164 | 113.51 | 3.24% | -0.46%↓ |
| Shilpa Medicare Ltd. | Healthcare | 10,80,751 | 113.18 | 3.23% | 0.13%↑ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 9,04,958 | 111.58 | 3.19% | 1.29%↑ |
| Acutaas Chemicals Ltd. | Healthcare | 3,39,010 | 111.17 | 3.18% | -0.06%↓ |
| Anthem Biosciences Ltd. | Healthcare | 12,91,629 | 110.9 | 3.17% | -0.31%↓ |
| Ipca Laboratories Ltd. | Healthcare | 5,41,736 | 104.39 | 2.98% | -0.25%↓ |
| Global Health Ltd. | Healthcare | 6,98,170 | 95.3 | 2.72% | -0.13%↓ |
| Rubicon Research Ltd. | Healthcare | 5,44,383 | 88.16 | 2.52% | -0.30%↓ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 9,84,676 | 73.5 | 2.10% | -0.15%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 3,12,887 | 73.05 | 2.09% | -0.25%↓ |
| Molbio Diagnostics Ltd. | Healthcare | 5,38,006 | 70.42 | 2.01% | 0.24%↑ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 96.77% | 98.42% | 99.53% | 97.25% | 98.68% | 97.30% |
25.0 / 100
Weighted average Value score is 25.0. This indicates that portfolio is relatively overvalued using composite of value measures.
74.3 / 100
Weighted average Price Momentum score is 74.3. This indicates that portfolio has average momentum using composite of momentum measures.
86.6 / 100
Weighted average Quality score is 86.6. This indicates that portfolio has high quality using composite of quality measures.
72.8 / 100
Weighted average QVM score is 72.8. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
